The α-linolenic acid content of flaxseed can prevent the atherogenic effects of dietary trans fat

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 6, 2011, Pages 2220-2226

  Bassett, Chantal M C ^a   Mccullough, Richelle S ^a   Edel, Andrea L ^a   Patenaude, Amanda ^a   Lavallee, Renee K ^a   Pierce, Grant N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Atherosclerosis; Linseed; Omega 3 fatty acids; Plaque; Trans fatty acids

Indexed keywords

LINOLENIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR; TRANS FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HEART PROTECTION; LINSEED; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALPHA-LINOLENIC ACID; ANIMALS; AORTIC DISEASES; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; DIETARY FATS, UNSATURATED; DIETARY FIBER; DISEASE MODELS, ANIMAL; FEMALE; FLAX; LIGNANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLANT PREPARATIONS; RECEPTORS, LDL; SEEDS; TIME FACTORS; TRANS FATTY ACIDS; TRIGLYCERIDES;

EID: 82955225039     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00958.2010     Document Type: Article

References (48)

1. Allman MA, Pena MM, Pang D. Supplementation with flaxseed oil versus sunflower seed oil in healthy young men consuming a low fat diet: effects on platelet composition and function. Eur J Clin Nutr 49: 169-178, 1995.
2. 2+ exchanger to alphalinolenic acid. Cardiovasc Res 73: 395-403, 2007.
3. Anon. Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser 916: 1-8, 1-149, backcover, 2003.
4. Anon. Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. Final rule. Fed Regist 68: 41433-41506, 2003.
5. -/- mice. J Nutr 140: 18-24, 2010.
6. Bassett CM, McCullough RS, Edel AL, Maddaford TG, Dibrov E, Blackwood DP, Austria JA, Pierce GN. Trans-fatty acids in the diet stimulate atherosclerosis. Metabolism 58: 1802-1808, 2009.
7. Bloedon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, Szapary PO. Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 27: 65-74, 2008.
8. Breslow JL. Mouse models of atherosclerosis. Science 272: 685-688, 1996.
9. Cassagno N, Palos-Pinto A, Costet P, Breilh D, Darmon M, Berard AM. Low amounts of trans 18:1 fatty acids elevate plasma triacylglycerols but not cholesterol and alter the cellular defence to oxidative stress in mice. Br J Nutr 94: 346-352, 2005.
10. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63: 116-122, 1996.
11. Clifton PM, Keogh JB, Noakes M. Trans fatty acids in adipose tissue and the food supply are associated with myocardial infarction. J Nutr 134: 874-879, 2004.
12. Djousse L, Arnett DK, Carr JJ, Eckfeldt JH, Hopkins PN, Province MA, Ellison RC. Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 111: 2921-2926, 2005.
13. Djousse L, Arnett DK, Pankow JS, Hopkins PN, Province MA, Ellison RC. Dietary linolenic acid is associated with a lower prevalence of hypertension in the NHLBI Family Heart Study. Hypertension 45: 368-373, 2005.
14. Dlouhy P, Tvrzicka E, Stankova B, Vecka M, Zak A, Straka Z, Fanta J, Pachl J, Kubisova D, Rambouskova J, Bilkova D, Andel M. Higher content of 18:1 trans fatty acids in subcutaneous fat of persons with coronarographically documented atherosclerosis of the coronary arteries. Ann Nutr Metab 47: 302-305, 2003.
15. Dupasquier CM, Dibrov E, Kneesh AL, Cheung PK, Lee KG, Alexander HK, Yeganeh BK, Moghadasian MH, Pierce GN. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am J Physiol Heart Circ Physiol 293: H2394-H2402, 2007.
16. Dupasquier CM, Weber AM, Ander BP, Rampersad PP, Steigerwald S, Wigle JT, Mitchell RW, Kroeger EA, Gilchrist JS, Moghadasian MM, Lukas A, Pierce GN. Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. Am J Physiol Heart Circ Physiol 291: H2987-H2996, 2006.
17. Erkkila AT, Lehto S, Pyorala K, Uusitupa MI. n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. Am J Clin Nutr 78: 65-71, 2003.
18. Health Canada. TRANSforming the Food Supply-Report of the Trans Fat Task Force Ottawa, Ontario, Canada: Ministry of Health, 2006.
19. Hu FB, Stampfer MJ, Manson JE, Rimm EB, Wolk A, Colditz GA, Hennekens CH, Willett WC. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 69: 890-897, 1999.
20. Hu H, Pierce GN, Zhong G. The atherogenic effects of chlamydia are dependent upon serum cholesterol and specific to the chlamydia pneumoniae species. J Clin Invest 103: 747-753, 1999.
21. Jenkins DJ, Kendall CW, Vidgen E, Agarwal S, Rao AV, Rosenberg RS, Diamandis EP, Novokmet R, Mehling CC, Perera T, Griffin LC, Cunnane SC. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am J Clin Nutr 69: 395-402, 1999.
22. Lamotte M, Annemans L, Kawalec P, Zoellners Y. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction. Herz 31, Suppl 3: 74-82, 2006.
23. Leth T, Jensen HG, Mikkelsen AA, Bysted A. The effect of the regulation on trans fatty acid content in Danish food. Atherosclerosis 7, Suppl: 53-56, 2006.
24. Lopez-Garcia E, Schulze MB, Meigs JB, Manson JE, Rifai N, Stampfer MJ, Willett WC, Hu FB. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 135: 562-566, 2005.
25. Lucas EA, Lightfoot SA, Hammond LJ, Devareddy L, Khalil DA, Daggy BP, Smith BJ, Westcott N, Mocanu V, Soung do Y, Arjmandi BH. Flaxseed reduces plasma cholesterol and atherosclerotic lesion formation in ovariectomized Golden Syrian hamsters. Atherosclerosis 173: 223-229, 2004.
26. Mandasescu S, Mocanu V, Dascalita AM, Haliga R, Nestian I, Stitt PA, Luca V. Flaxseed supplementation in hyperlipidemic patients. Rev Med Chir Soc Med Nat Iasi 109: 502-506, 2005.
27. Mattar M, Obeid O. Fish oil and the management of hypertriglyceridemia. Nutr Health 20: 41-49, 2009.
28. Merkel M, Velez-Carrasco W, Hudgins LC, Breslow JL. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice. Proc Natl Acad Sci USA 98: 13294-13299, 2001.
29. New York City Department of Health and Mental Hygiene. Notice of the Adoption of an Amendment (81.08) to Article 81 of the New York City Health Code. New York: New York City Department of Health and Mental Hygiene, 2006.
30. nd Ed.). Ottawa, Canada: Bradda, 1993, vol. 1.
31. Paschos GK, Magkos F, Panagiotakos DB, Votteas V, Zampelas A. Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients. Eur J Clin Nutr 61: 1201-1206, 2007.
32. Patade A, Devareddy L, Lucas EA, Korlagunta K, Daggy BP, Arjmandi BH. Flaxseed reduces total and LDL cholesterol concentrations in Native American postmenopausal women. J Womens Health 17: 355-366, 2008.
33. Prasad K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 132: 69-76, 1997.
34. Prasad K. Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed. Atherosclerosis 179: 269-275, 2005.
35. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 99: 1355-1362, 1999.
36. Prasad K, Mantha SV, Muir AD, Westcott ND. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alphalinolenic acid. Atherosclerosis 136: 367-375, 1998.
37. Renier G, Skamene E, DeSanctis J, Radzioch D. Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities. Arterioscler Thromb 13: 1515-1524, 1993.
38. Rodriguez-Leyva D, Dupasquier CMC, McCullough R, Pierce GN. The omega-3 fatty acid alpha linolenic acid within flaxseed provides beneficial cardiovascular effects. Can J Cardiol 26: 489-496, 2010.
39. Rudel LL, Kelley K, Sawyer JK, Shah R, Wilson MD. Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptornull, human ApoB100-overexpressing transgenic mice. Arterioscler Thromb Vasc Biol 18: 1818-1827, 1998.
40. Sano T, Oda E, Yamashita T, Shiramasa H, Ijiri Y, Yamamoto J. Antithrombic and anti-atherogenic effects of partially defatted flaxseed meal using a laser-induced thrombosis test in apolipoprotein E and low-density lipoprotein receptor deficient mice. Blood Coagul Fibrinolysis 14: 707-712, 2003.
41. Stachowska E, Dolegowska B, Chlubek D, Wesolowska T, Ciechanowski K, Gutowski P, Szumilowicz H, Turowski R. Dietary trans fatty acids and composition of human atheromatous plaques. Eur J Nutr 43: 313-318, 2004.
42. Sundram K, French MA, Clandinin MT. Exchanging partially hydrogenated fat for palmitic acid in the diet increases LDL-cholesterol and endogenous cholesterol synthesis in normocholesterolemic women. Eur J Nutr 42: 188-194, 2003.
43. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, Gallagher PJ, Calder PC, Grimble RF. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet 361: 477-485, 2003.
44. Thies F, Miles EA, Nebe-von-Caron G, Powell JR, Hurst TL, Newsholme EA, Calder PC. Influence of dietary supplementation with longchain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 36: 1183-1193, 2001.
45. von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 130: 554-562, 1999.
46. Wendland E, Farmer A, Glasziou P, Neil A. Effect of alpha linolenic acid on cardiovascular risk markers: a systematic review. Heart 92: 166-169, 2006.
47. Willett WC. Trans fatty acids and cardiovascular disease-epidemiological data. Atheroscler 7, Suppl: 5-8, 2006.
48. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, Sampson LA, Hennekens CH. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341: 581-585, 1993.